bpc-157 legal status canada health canada Research Guide 2026: Sourcing, and Compliance Public advisory - Unauthorized injectable
Public advisory Unauthorized injectable peptide drugs sold by Prime Research may pose serious health risks BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Health Product InfoWatch: December 2024 The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University BPC 157 Peptide: Benefits for Healing, Recovery & Nerve Repair Doctors are using a regulatory gap to prescribe an unauthorized peptide CBC News
Pay in 4 interest-free payments of $5.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




